Prevalence and Risk Factors for CTX-M Gram-negative Bacteria in Hospitalized Patients at a Tertiary Care Hospital in Kilimanjaro, Tanzania
Overview
Microbiology
Authors
Affiliations
Emergence and spread of extended spectrum beta-lactamase (ESBL)-producing gram-negative bacteria, mainly due to CTX-M, is a major global public health problem. Patients infected with ESBL-producing gram-negative bacteria have an increased risk of treatment failure and death. We investigated the prevalence and risk factors for CTX-M gram-negative bacteria isolated from clinical specimens of patients hospitalized at a tertiary care hospital in Kilimanjaro, Tanzania. Isolated gram-negative bacteria from inpatients admitted at Kilimanjaro Christian Medical Centre (KCMC) between August 2013 and August 2015 were fully genome sequenced. The prevalence of ESBL-producing gram-negative bacteria was determined based on the presence of bla. The odds ratio (OR) and risk factors for ESBL-producing gram-negative bacteria due to CTX-M were assessed using logistic regression models. The overall CTX-M prevalence (95% CI) was 13.6% (10.1-18.1). Adjusted for other factors, the OR of CTX-M gram-negative bacteria for patients previously hospitalized was 0.26 (0.08-0.88), p = 0.031; the OR for patients currently on antibiotics was 4.02 (1.29-12.58), p = 0.017; the OR for patients currently on ceftriaxone was 0.14 (0.04-0.46), p = 0.001; and the OR for patients with wound infections was 0.24 (0.09-0.61), p = 0.003. The prevalence of ESBL-producing gram-negative bacteria due to CTX-M in this setting is relatively low compared to other previous reports in similar settings. However, to properly stop further spread in the hospital, we recommend setting up a hospital surveillance system that takes full advantage of the available next-generation sequencing facility to routinely screen for all types of bacterial resistance genes.
Kengne M, Mbaveng A, Karimo O, Dadjo B, Tsobeng O, Marbou W Int J Microbiol. 2024; 2024:7685878.
PMID: 38962396 PMC: 11222006. DOI: 10.1155/2024/7685878.
Antibiotic use at a tertiary hospital in Tanzania: findings from a point prevalence survey.
Katyali D, Kawau G, Blomberg B, Manyahi J Antimicrob Resist Infect Control. 2023; 12(1):112.
PMID: 37817204 PMC: 10566109. DOI: 10.1186/s13756-023-01317-w.
Muzaheed , Sattar Shaikh N, Shaikh S, Acharya S, Moosa S, Shaikh M F1000Res. 2021; 10:444.
PMID: 34909182 PMC: 8596178. DOI: 10.12688/f1000research.53221.3.
Letara N, Ngocho J, Karami N, Msuya S, Nyombi B, Kassam N Sci Rep. 2021; 11(1):22759.
PMID: 34815472 PMC: 8611091. DOI: 10.1038/s41598-021-02186-2.
Onduru O, Mkakosya R, Aboud S, Rumisha S Can J Infect Dis Med Microbiol. 2021; 2021:5153237.
PMID: 34122680 PMC: 8192179. DOI: 10.1155/2021/5153237.